![Robert Thomas Dorr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Robert Thomas Dorr is the founder of Clinuvel Pharmaceuticals Ltd., founded in 1999.
He is also the founder of AmpliMed Corp., founded in 1989.
At AmpliMed Corp., he held the title of President & Chief Executive Officer from 2009 to 2014.
Currently, Dr. Dorr is working at Arizona Cancer Center as Professor & Director-Pharmacology Program.
Dr. Dorr is also the founder of Paladin Corp...
Aktive Positionen von Robert Thomas Dorr
Unternehmen | Position | Beginn |
---|---|---|
Arizona Cancer Center
![]() Arizona Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of Arizona, Arizona Cancer Center provides clinical and medical research services. The company is based in Tucson, AZ. | Corporate Officer/Principal | - |
Paladin Corp. | Gründer | - |
Ehemalige bekannte Positionen von Robert Thomas Dorr
Unternehmen | Position | Ende |
---|---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Gründer | - |
AmpliMed Corp.
![]() AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
AmpliMed Corp.
![]() AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Health Technology |
Arizona Cancer Center
![]() Arizona Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of Arizona, Arizona Cancer Center provides clinical and medical research services. The company is based in Tucson, AZ. | Commercial Services |
Paladin Corp. |